S. Ida

发表

Active HIV-1 redistribution and replication in the brain with HIV encephalitis

S. Oka, A. Iwamoto, T. Shioda, 1999, Archives of Virology.

In vivo antiviral effects of mismatched double‐stranded RNA on duck hepatitis B virus

S. Ida, K. Mitamura, K. Mitamura, 1994, Journal of medical virology.

Determination of Hepatitis B Virus DNA in Serum by Molecular Hybridization

S. Ida, T. Yuasa, T. Matsukura, 1984, Microbiology and immunology.

Expansion of HIV-1-specific CD28- CD45RA- CD8+ T cells in chronically HIV-1-infected individuals.

G. Ogg, A. McMichael, S. Oka, 2000, AIDS.

Modified Dynabeads Method for Enumerating CD4+ T-Lymphocyte Count for Widespread Use in Resource-Limited Situations

S. Oka, H. Gatanaga, M. Honda, 2005, Journal of acquired immune deficiency syndromes.

Laboratory and Epidemiology Communications Rate of Subclinical Hepatitis A Virus Infection in Adult HIV- 1 -Infected Patients

S. Oka, N. Tachikawa, Y. Kikuchi, 2001 .

Urinary Coproporphyrin isomers in Rotor's syndrome: A study in eight families

M. Kohakura, S. Ida, H. Naruto, 1981, Hepatology.

Comparison of Antiviral Effects of Mismatched Double-Stranded RNA and 1 -(2′-Deoxy-2′,-Fluoro-β-D-Arabinofuranosyl)-5-Methyluracil (D-FMAU) against Duck Hepatitis B virus in Vitro

S. Ida, K. Mitamura, K. Shimada, 1997 .

Rapid and Simple Phenotypic Assay for Drug Susceptibility of Human Immunodeficiency Virus Type 1 Using CCR5-Expressing HeLa/CD4+ Cell Clone 1-10 (MAGIC-5)

S. Oka, A. Kojima, A. Hachiya, 2001, Antimicrobial Agents and Chemotherapy.

Influence of human immunodeficiency virus type 1 infection on acute hepatitis A virus infection.

S. Oka, N. Tachikawa, M. Daikoku, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Further studies on antibodies to early antigens induced by Epstein-Barr virus in nasopharyngeal carcinoma patients.

J. Chiou, S. Ida, Y. Hinuma, 1973, Gan.

Antibodies to a new antigen induced by Epstein-Barr virus in patients with nasopharyngeal carcinoma, leukemia, malignant lymphoma, and in control groups.

T. Sairenji, S. Ida, Y. Hinuma, 1972, Gan.

A naturally occurring single basic amino acid substitution in the V3 region of the human immunodeficiency virus type 1 env protein alters the cellular host range and antigenic structure of the virus

S. Oka, Y. Takebe, Y. Nagai, 1994, Journal of virology.

Genetic analysis of HIV-1 during rapid progression to AIDS in an apparently healthy man.

S. Oka, Y. Takebe, T. Shioda, 1994, AIDS research and human retroviruses.

Identification and characterization of HLA-A*3303-restricted, HIV type 1 Pol- and Gag-derived cytotoxic T cell epitopes.

S. Oka, M. Takiguchi, S. Ida, 2003, AIDS research and human retroviruses.

Excretion of porphyrins in urine and bile after the administration of delta-aminolevulinic acid.

S. Ida, S Ida, Y Shimizu, 1978, The Journal of laboratory and clinical medicine.

Emergence of Protease Inhibitor Resistance–Associated Mutations in Plasma HIV-1 Precedes That in Proviruses of Peripheral Blood Mononuclear Cells by More Than a Year

S. Oka, H. Gatanaga, K. Tsuchiya, 2003, Journal of acquired immune deficiency syndromes.

HIV type 1 V3 variation dynamics in vivo: long-term persistence of non-syncytium-inducing genotypes and transient presence of syncytium-inducing genotypes during the course of progressive AIDS.

S. Oka, Y. Nagai, A. Iwamoto, 1997, AIDS research and human retroviruses.

Influence of human immunodeficiency virus type 1 infection on acute hepatitis A virus infection.

S. Oka, N. Tachikawa, M. Daikoku, 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.